-
THE SCALE OF PROLONGED UNCERTAINTY: ESTIMATING U.S. PATIENT POPULATIONS AFFECTED BY OVERDUE ACCELERATED APPROVAL CONFIRMATORY TRIALS
Mar 18, 2026, 21:38 PM -
CONFIDENCE INTERVALS FOR EVENT-BASED NUMBER NEEDED TO TREAT: A PRACTICAL APPROACH FOR HEALTH ECONOMIC EVALUATION OUTPUTS
Mar 18, 2026, 21:38 PM -
ECONOMIC OUTCOMES, REAL-WORLD ADHERENCE PATTERNS AND PREDICTIVE MODELING OF MIGRAINE PROPHYLAXIS: A RETROSPECTIVE COHORT STUDY OF TRIPTANS, BETA-BLOCKERS, AND COMBINATION THERAPY
Mar 18, 2026, 21:38 PM -
ENSURING STUDY VALIDITY TO INFORM HEALTH TECHNOLOGY ASSESSMENTS GLOBALLY
Mar 18, 2026, 21:38 PM -
REAL-WORLD ADOPTION, BARRIERS, ARTIFICIAL INTELLIGENCE INTEGRATION, AND FUTURE READINESS OF ROBOTIC-ASSISTED SURGERY (RAS) IN CHINA
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS ANALYSIS OF GLP-1 RA TO PREVENT TYPE 2 DIABETES AMONG TEENAGERS IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
EFFECT OF STATIN USE ON THE RISK OF ADVANCED LIVER DISEASE AND MORTALITY AMONG PATIENTS WITH CHRONIC LIVER DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS
Mar 18, 2026, 21:38 PM -
HEALTHCARE RESOURCE UTILIZATION (HRU) AND COSTS IN US PATIENTS WITH 2L+ RECURRENT OR PROGRESSIVE ENDOMETRIAL CANCER (EC)
Mar 18, 2026, 21:38 PM -
NEUROLOGICAL EFFECTS OF COMBINED EXPOSURE TO ORGANOPHOSPHATE AND PYRETHROID PESTICIDES: A SYSTEMATIC REVIEW AND META-ANALYSIS
Mar 18, 2026, 21:38 PM -
IMPORTANCE OF INTERMEDIATE CLINICAL ENDPOINTS (ICES) IN PROSTATE CANCER (PC) FOR PATIENTS: A CLUSTER ANALYSIS
Mar 18, 2026, 21:38 PM -
ACCOUNTING FOR RISK-AVERSION IN HEALTH TECHNOLOGY ASSESSMENT: UTILITY ESTIMATION ACROSS MULTIPLE HEALTH INDEXES IN NON-SMALL CELL LUNG CANCER
Mar 18, 2026, 21:38 PM -
INSIGHTS INTO RANGE OF MOTION (ROM) AND PHYSICAL FUNCTION (PF) CHANGES EXPERIENCED BY PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR (TGCT) IN THE MANEUVER PHASE 3 TRIAL: RESULTS FROM EXIT INTERVIEWS
Mar 18, 2026, 21:38 PM -
LEARNING THE CAUSAL STRUCTURE OF MENTAL HEALTH LITERACY DIMENSIONS FROM OBSERVATIONAL DATA: A MULTI-METHOD CAUSAL DISCOVERY STUDY
Mar 18, 2026, 21:38 PM -
COST-MINIMIZATION ANALYSIS OF DAMOCTOCOG ALFA PEGOL VERSUS EMICIZUMAB PROPHYLAXIS IN PATIENTS WITH SEVERE HEMOPHILIA A WITHOUT INHIBITORS IN COLOMBIA, PERU AND COSTA RICA
Mar 18, 2026, 21:38 PM -
INDIRECT TREATMENT COMPARISON OF ODEVIXIBAT AND MARALIXIBAT FOR THE TREATMENT OF CHOLESTATIC PRURITUS IN PATIENTS WITH ALAGILLE SYNDROME (ALGS)
Mar 18, 2026, 21:38 PM -
USE OF NOVEL ELEMENTS OF VALUE IN COST-EFFECTIVENESS ANALYSES: INSIGHTS FROM THE CEA REGISTRY (2016-2024)
Mar 18, 2026, 21:38 PM -
QUALITY OF LIFE AND PRODUCTIVITY LOSS COSTS OF NERVE BLOCK WITH DEEPLY INSERTED ACUPOTOMY VERSUS NERVE BLOCK ALONE IN LUMBOSACRAL RADICULOPATHY
Mar 18, 2026, 21:38 PM -
THE ROLE OF TRANSFER LEARNING ON THE PERFORMANCE OF MACHINE LEARNING MODELS ACROSS RACIAL/ETHNIC GROUPS
Mar 18, 2026, 21:38 PM -
BUDGETARY IMPLICATIONS OF REPLACING PATENTED SEVELAMER IN THE MANAGEMENT OF CHRONIC KIDNEY DISEASE IN MEXICO
Mar 18, 2026, 21:38 PM -
ECOA METATEXT DEVELOPMENT: AN ESSENTIAL STEP IN MAINTAINING UX/UI ACROSS ALL LANGUAGES IN ECOA SOLUTIONS
Mar 18, 2026, 21:38 PM
